Skip to main content

An official website of the United States government

You have 2 new alerts

Notice of Intent to Sole Source

info alert

Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.

General Information

  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Feb 23, 2022 02:20 am EST
  • Original Response Date: Feb 28, 2022 10:00 am EST
  • Inactive Policy: 15 days after response date
  • Original Inactive Date:
  • Initiative:
    • None

Classification

  • Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
  • Product Service Code: AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Silver Spring , MD 20993
    USA

Description

The purpose of this synopsis is to announce the Food and Drug Administration's intent to issue a Sole Source Purchase Order for Fresh Primary Human Hepatocyte Cultures.

THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS, however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency by Monday, February 28, 2022 @ 10:00 AM Eastern Time to Nina Montgomery, Contract Specialist, Email: Nina.Montgomery@fda.hhs.gov. 

Contact Information

Contracting Office Address

  • 5630 Fishers Lane
  • Rockville , MD 20841
  • US

Primary Point of Contact

Secondary Point of Contact





History